Skip to main content
Premium Trial:

Request an Annual Quote

Kapa Biosystems Extends Distribution Pact with Nippon Genetics

NEW YORK (GenomeWeb) — Kapa Biosystems said today that it has signed a three-year exclusive distribution agreement with Nippon Genetics.

The agreement extends an existing seven-year relationship between the companies and enables Nippon to continue marketing, distributing, and servicing Kapa's genomics reagents in Japan.

Kapa, based in Wilmington, Mass., sells reagents for use in PCR, qPCR, next-generation sequencing, and molecular diagnostics. Nippon is headquartered in Tokyo and provides a range of genomic and molecular biology research products for applications such as nucleic acid separation and purification, electrophoresis, PCR, real-time PCR, and NGS library prep.

"We are seeing broad adoption and strong demand for our innovative products not only in Japan, but across the Asia Pacific, European, and North American regions," Jean-Christophe Hatinguais, director of international sales at Kapa Biosystems, said in a statement. "We are now focused on extending our global reach by increasing our strategic investments and expanding our distribution network in key markets."

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.